Clinical Trial Update: Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the CLAG-M regimen (cladribine, cytarabine, mitoxantrone, filgrastim) in relapsed acute lymphoblastic leukemia; current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma
• Lymphoblastic Lymphoma
• Myelogenous Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cladribine (cladribine)
• Filgrastim (filgrastim)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: New York Medical College | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | Status: UNKNOWN